Chair and CEO, Ondine Biomedical Inc.
Carolyn Cross is a Founder of Ondine Biomedical Inc., a Vancouver based Medical Devices Company, and currently serves as the Chairman and Chief Executive Officer of the Company. She also is a Board Member and Treasurer of the International Photodynamic Association. As the global leader in antimicrobial photodynamic solutions, Ondine is dedicated to the development of non‐antibiotic anti‐infective therapies for a broad spectrum of bacterial, viral and fungal infections, working from its photodisinfection technology platform. Earlier in her career, Ms. Cross was responsible for managing pension, pooled, mutual and private client funds as a Vice President with Royal Bank Investment Management Inc., the fund management arm of the Royal Bank of Canada. Ms. Cross has over 20 years direct experience with early stage companies and 30 years’ experience with public market securities. She currently sits on several corporate boards including Periowave Dental Technologies, Inc., Sinuwave Technologies Corporation, Antares Project Services Ltd., OrGenX Biopharma Corporation and others. She is currently serving as a Board Member of the Canadian Foundation for Innovation (CFI), the Advisory Board of McGill University Dental School and The Vimy Foundation. She is a Founding Member of the Ernst & Young Global Women in Business Advisory Council as well as the Women’s Economic Business Advisory Council. Ms. Cross is a member of the Women Presidents’ Organization, TEC Canada, the International Federation of Women, the Toronto Society of Financial Analysts, and the Courthill Foundation. She is a recipient of the Queen Elizabeth Diamond Jubilee Medal.